[Interview with Professor Eric Fossion on the subject of bisphosphonates. Interview by Th van Nuijs].
Th. van Nuijs, chief editor of the Revue Belge de Médecine Dentaire, interviews Professor Eric Fossion on the problematic of bisphosfonates and their role in the osteonecrosis of the jaws. Prof. Eric Fossion is maxillo-facial surgeon. Actually, he is professor part-time at the Catholic University of Leuven. He is Head Department of Dentistry, Oral and Maxillofacial Surgery, Middelheim Hospital, Antwerp.
Fossion
Eric
E
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D016723:Bone Remodeling / Q000187:drug effects; D000075202:Contraindications; D004164:Diphosphonates / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D006207:Half-Life; D006801:Humans; D007568:Jaw / Q000098:blood supply / Q000378:metabolism; D007571:Jaw Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000378:metabolism; D008875:Middle Aged; D019647:Oral Surgical Procedures; D010006:Osteoblasts / Q000187:drug effects; D010020:Osteonecrosis / Q000139:chemically induced* / Q000188:drug therapy / Q000378:metabolism; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D014945:Wound Healing / Q000502:physiology
D000900:Anti-Bacterial Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates